By Michele Maatouk
Date: Thursday 10 Sep 2026
(Sharecast News) - Animal genetics firm Genus reported a rise in full-year profit on Thursday and announced a £60m share buyback, but shares slumped as revenue missed expectations.
By Frank Prenesti
Date: Tuesday 14 Jul 2026
(Sharecast News) - Animal genetics company Genus on Tuesday said it expected annual earnings to be moderately above expectations after a strong second half in Asia and Latin America that more than offset weaker conditions in North America, sending shares in the firm 5% higher.
By Iain Gilbert
Date: Tuesday 14 Jul 2026
(Sharecast News) - Analysts at Berenberg maintained their 'buy' rating on Genus on Tuesday as it said the animal genetics firm's latest trading update showed strong momentum across the business, prompting another upgrade to full‑year guidance and extending what the broker described as a sustained run of improvements since early 2025.
| Currency | UK Pounds |
| Price | 2,130.00p |
| Change Today | -104.00p |
| 52 Week High | 3,170.00p |
| 52 Week Low | 1,966.00p |
| Volume | 353,807 |
| Shares Issued | 66.54m |
| Market Cap | £1,417.32m |
| Strong Buy | 6 |
| Buy | 1 |
| Neutral | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 8 |
